Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01415089 · ClinicalTrials.gov registry record · NA
Tailored Web-Based Intervention for Cancer Patients and Family Caregivers
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT01415089: Completed NA study, sponsored by University of Michigan.
NCT01415089 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 63 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01415089, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to develop a personalized, interactive, and web-based module for cancer patients and a family caregiver. The three-session module will be designed to help patients and family caregivers improve their communication and support.
Primary Outcome
A preliminary assessment of the magnitude of the pilot intervention effects on patients' and family caregivers' level of quality of life (FACT-G Scale) will be conducted.
Interventions
- BEHAVIORAL FOCUS-Web
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT01415089 record still lists
NCT01415089 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which FOCUS-Web is the first listed.
NCT01415089 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01415089 about?
NCT01415089 is a clinical study titled "Tailored Web-Based Intervention for Cancer Patients and Family Caregivers". The purpose of this pilot study is to develop a personalized, interactive, and web-based module for cancer patients and a family caregiver. The three-session module will be designed to help patients and family caregivers improve their communication and support.
What is the current status of trial NCT01415089?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2009-05. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01415089?
The interventions under investigation include: FOCUS-Web (BEHAVIORAL).
Who is sponsoring clinical trial NCT01415089?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01415089's enrollment target sits among peer trials
63 1157th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia